LY18-02a

Main Content

Effect of time to relapse on overall survival in mantle cell lymphoma patients following frontline autologous stem cell transplant.

Study #: LY18-02a

Study Status: Published

Presentation(s)

2021, ASCO (Poster)

Outcomes and utilization trends of front-line autologous hematopoietic cell transplantation for mantle cell lymphoma.

Citation

Riedell PA, Hamadani M, Ahn KW, Litovich C, Murthy GSG, Locke FL, Brunstein CG, Merryman RW, Stiff PJ, Pawarode A, Nishihori T, Kharfan-Dabaja MA, Herrera AF, Sauter CS, Smith SM.

Transplantation and Cellular Therapy. 2021, Nov 01: 27(11): 27(11):911.e1-911.e7. doi: 10.1016/j.jtct.2021.08.014. Epub 2021, Aug 24. PMCID:PMC8556305.

PubMed

PMID: 34450333

Abstract